Gene · 2222
Papers2,006
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,006
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| In Silico Analysis of Selected Mikania Constituents As Human HMG-CoA Reductase, Human Inducible Nitric Oxide Synthase, and Human Squalene Synthase Inhibitory Agents. | Cureus | 2024 | 38558754 | PubTator, text mining | PubMed |
| Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis. | Int J Surg | 2024 | 38502850 | PubTator, text mining | PubMed |
| Identification and prognostic analysis of ferroptosis‑related gene HSPA5 to predict the progression of lung squamous cell carcinoma. | Oncol Lett | 2024 | 38464337 | PubTator, text mining | PubMed |
| Enhanced production of withaferin A from the hairy root culture of Withania somnifera via synergistic effect of Methyl jasmonate and β-cyclodextrin. | Plant Physiol Biochem | 2024 | 38412705 | PubTator, text mining | PubMed |
| Repurposing screen identifies novel candidates for broad-spectrum coronavirus antivirals and druggable host targets. | Antimicrob Agents Chemother | 2024 | 38319076 | PubTator, text mining | PubMed |
| A multidimensional atlas of human glioblastoma-like organoids reveals highly coordinated molecular networks and effective drugs. | NPJ Precis Oncol | 2024 | 38273014 | PubTator, text mining | PubMed |
| Ferroptosis: Emerging mechanisms, biological function, and therapeutic potential in cancer and inflammation. | Cell Death Discov | 2024 | 38267442 | PubTator, text mining | PubMed |
| In silico investigation of cholesterol-lowering drugs to find potential inhibitors of dehydrosqualene synthase in Staphylococcus aureus. | 3 Biotech | 2024 | 38261920 | PubTator, text mining | PubMed |
| Impact of De Novo Cholesterol Biosynthesis on the Initiation and Progression of Breast Cancer. | Biomolecules | 2024 | 38254664 | PubTator, text mining | PubMed |
| Cytotoxic Effects of Major and Emerging Mycotoxins on HepaRG Cells and Transcriptomic Response after Exposure of Spheroids to Enniatins B and B1. | Toxins (Basel) | 2024 | 38251270 | PubTator, text mining | PubMed |
| Intramembrane protease SPP defines a cholesterol-regulated abundance control of the mevalonate pathway enzyme squalene synthase. | J Biol Chem | 2024 | 38218226 | PubTator, text mining | PubMed |
| Ranibizumab Modifies the Expression of Metalloproteinases and Their Tissue Inhibitors in Peripheral Blood Mononuclear Cells in Patients with Exudative Age-Related Macular Degeneration. | J Clin Med | 2024 | 38202302 | PubTator, text mining | PubMed |
| Harnessing postharvest light emitting diode (LED) technology of Centella asiatica (L.) Urb. to improve centelloside content by up-regulating gene expressions in the triterpenoid pathway. | Heliyon | 2024 | 38192854 | PubTator, text mining | PubMed |
| Identification of key genes and regulatory mechanisms in adult degenerative scoliosis. | J Clin Neurosci | 2024 | 38103507 | PubTator, text mining | PubMed |
| Quantitative Proteomics of Tissue-Infiltrating T Cells From CRC Patients Identified Lipocalin-2 Induces T-Cell Apoptosis and Promotes Tumor Cell Proliferation by Iron Efflux. | Mol Cell Proteomics | 2024 | 38072118 | PubTator, text mining | PubMed |
| The RORɣ/SREBP2 pathway is a master regulator of cholesterol metabolism and serves as potential therapeutic target in t(4;11) leukemia. | Oncogene | 2024 | 38030791 | PubTator, text mining | PubMed |
| Lipid metabolism-associated genes serve as potential predictive biomarkers in neoadjuvant chemoradiotherapy combined with immunotherapy in rectal cancer. | Transl Oncol | 2024 | 38000147 | PubTator, text mining | PubMed |
| EMC rectifies the topology of multipass membrane proteins. | Nat Struct Mol Biol | 2024 | 37957425 | PubTator, text mining | PubMed |
| Novel Insights on Ferroptosis Modulation as Potential Strategy for Cancer Treatment: When Nature Kills. | Antioxid Redox Signal | 2024 | 37132605 | PubTator, text mining | PubMed |
| Ferroptosis: a dual-edged sword in tumour growth. | Front Pharmacol | 2023 | 38273826 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2222/papers?page=7